US Edition
Published • loading... • Updated
New Clinical Trial Conducted at Sheppard Pratt Identifies Predictors of Response to Vagus Nerve Stimulation for Treatment-Resistant Depression
- The Journal of Clinical Psychiatry published results from the RECOVER trial, which studied vagus nerve stimulation therapy for treatment-resistant depression.
- Findings indicate that prior exposure to electroconvulsive therapy or transcranial magnetic stimulation predicts treatment outcomes, with higher response rates for those without previous exposure.
- Patients in the subgroup with no prior treatments showed greater benefits from active vagus nerve stimulation compared to sham treatment.
Insights by Ground AI
40 Articles
40 Articles
Bennington Banner+39 Reposted by 39 other sources
New Clinical Trial Conducted at Sheppard Pratt Identifies Predictors of Response to Vagus Nerve Stimulation for Treatment-Resistant Depression
BALTIMORE, Oct. 13, 2025 /PRNewswire/ -- The Journal of Clinical Psychiatry recently published results from the RECOVER trial, a landmark study examining vagus nerve stimulation (VNS) therapy in individuals with treatment-resistant depression. The analysis, led by Scott T. Aaronson, MD,…
Coverage Details
Total News Sources40
Leaning Left3Leaning Right4Center9Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 19%
C 56%
R 25%
Factuality
To view factuality data please Upgrade to Premium
